WANBURY
|
The Current P/E Ratio of WANBURY is 14.86.
Share Price | ₹239.9 | Jan 10,2025 |
Market Cap | ₹786.9 Cr | |
Earnings-TTM | ₹53.0 Cr | TTM-Consolidated Results |
Price/Earnings | 14.86x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of WANBURY
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹786.9 Cr] as on Jan 10,2025
(/) Earnings [ ₹53.0 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 14.86x ]
Thus, for WANBURY , the investors are currently willing to pay 14.86 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of WANBURY !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of WANBURY over the last five years.
Historical PE (Price/Earnings) ratio chart of WANBURY
PE Ratio Performance Analysis for WANBURY
- WANBURY 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 2.53x.
- WANBURY 's operated at median p/e ratio of 0.71x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, WANBURY 's p/e ratio peaked in Mar2024 at 8.54x.
- WANBURY 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does WANBURY 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
WANBURY | 52.96 | 14.86 | 786.9 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,136.50 | 38.48 | 428,533.0 |
CIPLA LTD | 4,485.22 | 26.47 | 118,723.0 |
DR REDDYS LABORATORIES LTD | 5,406.80 | 20.90 | 112,998.0 |
ZYDUS LIFESCIENCES LTD | 4,298.90 | 23.50 | 101,031.0 |
DIVIS LABORATORIES LTD | 1,836.00 | 83.37 | 153,076.0 |
MANKIND PHARMA LTD | 2,124.86 | 53.17 | 112,971.0 |
TORRENT PHARMACEUTICALS LTD | 1,802.00 | 61.53 | 110,870.0 |
LUPIN LTD | 2,651.94 | 37.68 | 99,938.2 |
AUROBINDO PHARMA LTD | 3,598.83 | 19.37 | 69,702.0 |
ABBOTT INDIA LTD | 1,284.66 | 47.62 | 61,179.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs WANBURY 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 14.86x |
Max industry PE | 83.37x |
Median industry PE | 37.68x |
Average industry PE | 38.81x |
You may also like the below Video Courses